Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05294497 · ClinicalTrials.gov registry record · NA

CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches

A NA study of Smoking and Tobacco Use, sponsored by RAI Services Company.

Completed
Registry status
NA
Development phase
42
Enrollment target
2
Study locations

NCT05294497 is a NA study of Smoking and Tobacco Use that has completed, run by RAI Services Company. The registered enrollment target is 42 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05294497, a NA study of Smoking and Tobacco Use, has completed, sponsored by RAI Services Company.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
2
Study locations

Study Summary

This is a two-site, open-label, randomized, 6-way cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers.

Interventions

  • OTHER Product A
  • OTHER Product B
  • OTHER Product C
  • OTHER Product D
  • OTHER Product N

Study Locations (2)

Kentucky

  • AMR Lexington - Lexington

Tennessee

  • AMR Knoxville - Knoxville

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2022-05-01
Est. Completion 2022-05-27
Phase NA

Sponsor

RAI Services Company

42 total trials

What the Registry Record Tells You About NCT05294497

The ClinicalTrials.gov registry entry for NCT05294497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower). The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Smoking appearing as the primary indexed condition, and to 5 interventions - of which Product A is the first listed.

NCT05294497 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05294497 about?

NCT05294497 is a clinical study titled "CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches". This is a two-site, open-label, randomized, 6-way cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the s...

What is the current status of trial NCT05294497?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2022-05-01. Estimated completion is 2022-05-27.

What conditions does trial NCT05294497 study?

This clinical trial studies the following conditions: Smoking, Tobacco Use, Tobacco Smoking.

What interventions are being tested in trial NCT05294497?

The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product N (OTHER).

Who is sponsoring clinical trial NCT05294497?

This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05294497 being conducted?

This trial has 2 study locations across Kentucky, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.